Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	to evaluate the efficacy of Molnupiravir 800mg in the treatment of patients diagnosed with moderate COVID- 19.Timepoint: Proportion of patients with clinical improvement at Day 14	to evaluate the efficacy of Molnupiravir 800mg in the treatment of patients diagnosed with moderate COVID- 19.Timepoint: Proportion of patients with clinical improvement at Day 14
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Sept. 8, 2021, 1:30 a.m.	oms	to evaluate the efficacy of Molnupiravir 800mg in the treatment of patients diagnosed with moderate COVID- 19.Timepoint: Proportion of patients with clinical improvement at Day 14	to evaluate the efficacy of Molnupiravir 800mg in the treatment of patients diagnosed with moderate COVID- 19.Timepoint: Proportion of patients with clinical improvement at Day 14